Summary
Johnson & Johnson (JNJ) filed an 8-K on July 18, 2017, reporting its financial results for the second quarter ended July 2, 2017. The filing primarily consists of a press release and supplementary financial data, providing investors with details on the company's performance during the quarter. This information is crucial for understanding JNJ's ongoing operational strength and financial health. Investors should review the attached press release and supplementary sales data for a comprehensive understanding of the quarterly outcomes and their implications for the company's full-year outlook.
Key Highlights
- 1Johnson & Johnson released its Q2 2017 financial results on July 18, 2017.
- 2The report includes a press release detailing sales and earnings for the quarter ended July 2, 2017.
- 3The filing also contains unaudited comparative supplementary sales data.
- 4Investors can find a condensed consolidated statement of earnings for the second quarter.
- 5This 8-K filing serves as the official disclosure of JNJ's Q2 financial performance.
- 6The information provided is key for assessing the company's financial condition and operational results.